remacemide (Q7311505)

REMACEMIDE (English)

9 October 2016

C₁₇H₂₀N₂O

1 reference

REMACEMIDE (English)

18 November 2016

CC(CC1=CC=CC=C1)(C2=CC=CC=C2)NC(=O)CN

1 reference

REMACEMIDE (English)

18 November 2016

neuroprotective agent

1 reference

stated in

Medical Subject Headings

15 March 2018

1 reference

Medical Subject Headings

MeSH descriptor ID

C067553

InChI=1S/C17H20N2O/c1-17(19-16(20)13-18,15-10-6-3-7-11-15)12-14-8-4-2-5-9-14/h2-11H,12-13,18H2,1H3,(H,19,20)

15 March 2018

Identifiers

InChI

1 reference

REMACEMIDE (English)

18 November 2016

2 references

Global Substance Registration System

REMACEMIDE (English)

18 November 2016

ChEBI release 2020-09-01

CAS Registry Number

128298-28-2

2 references

stated in

UNII

EH6763C1IC

remacemide (English)

18 November 2016

https://commonchemistry.cas.org/detail?cas_rn=128298-28-2

9 April 2021

1 reference

Remacemide (English)

18 November 2016

2 references

English

title

REMACEMIDE (English)

18 November 2016

ChEBI ID

91654

mapping relation type

2 references

English

title

2-amino-N-(1,2-diphenylpropan-2-yl)acetamide (English)

9 October 2016

International Chemical Identifier

InChI

InChI=1S/C17H20N2O/c1-17(19-16(20)13-18,15-10-6-3-7-11-15)12-14-8-4-2-5-9-14/h2-11H,12-13,18H2,1H3,(H,19,20)

1 reference

REMACEMIDE (English)

18 November 2016

2 references

inferred from InChIKey

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

1 reference

2 references

DTXSID601030460

1 reference

DSSTOX compound identifier

0 references

1 reference

Medical Subject Headings

14 March 2018

1 reference

Human Metabolome Database ID

HMDB0257144

2 references

based on heuristic

inferred from InChIKey

Global Substance Registration System

UNII

EH6763C1IC

2 references

stated in

UNII

EH6763C1IC

English

title

remacemide (English)

18 November 2016

SVE7VVM49X

1 reference

Y65K7HQ8FU

1 reference